HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raminderjit Kaur Selected Research

Raminderjit Kaur Research Topics

Disease

2Inflammation (Inflammations)
01/2022 - 01/2018
2Neoplasms (Cancer)
01/2021 - 05/2019
2Type 2 Diabetes Mellitus (MODY)
05/2020 - 02/2019
1Latent Tuberculosis
01/2022
1Hyperplasia
01/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022
1Opportunistic Infections (Opportunistic Infection)
01/2022
1Osteosarcoma (Osteogenic Sarcoma)
05/2019
1Insulin Resistance
01/2018
1Hyperglycemia
01/2018

Drug/Important Bio-Agent (IBA)

2silk elastin-like protein (SELP)IBA
05/2020 - 02/2019
2SelectinsIBA
05/2020 - 02/2019
1Imiquimod (Aldara)FDA LinkGeneric
01/2022
1CytokinesIBA
01/2022
1Interleukin-17 (Interleukin 17)IBA
01/2022
1Type I Tumor Necrosis Factor ReceptorsIBA
01/2022
1Type II Tumor Necrosis Factor ReceptorsIBA
01/2022
1Interleukin-23 (Interleukin 23)IBA
01/2022
1enterocinIBA
01/2021
1SilverIBA
05/2019
1P-SelectinIBA
02/2019
1Nonesterified Fatty Acids (NEFA)IBA
01/2018

Therapy/Procedure

1Therapeutics
01/2022